v3.26.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Cash Flows From Operating Activities:    
Net loss $ (71,899) $ (53,981)
Net loss from discontinued operations (500) 0
Net loss from continuing operations (71,399) (53,981)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:    
Depreciation and amortization 29,446 26,818
Share based compensation 37,934 22,141
Foreign currency remeasurement impact 950 (2,165)
Inducement expense 40,008 0
Other (2,614) (693)
Changes in operating assets and liabilities:    
Accounts receivable (583) (11,486)
Inventory (3,450) 3,645
Prepaid expenses and other current and non-current assets (9,457) (6,777)
Accounts payable (17,211) (5,223)
Accrued expenses 9,194 (8,200)
Deferred revenue 0 (2,815)
Other current and non-current liabilities 4,887 1,525
Net cash provided by (used in) operating activities 17,705 (37,211)
Cash Flows From Investing Activities:    
Proceeds from the sale and maturity of marketable debt securities 85,149 134,553
Purchase of marketable debt securities (226,638) (64,371)
Purchase of intangible assets (43,249) (23,870)
Other 0 (172)
Net cash (used in) provided by investing activities (184,738) 46,140
Cash Flows From Financing Activities:    
Payment of guaranteed minimum royalty (1,050) (1,050)
Proceeds from issuance of 2032 convertible senior notes 525,000 0
Payment of debt issuance costs (16,270) 0
Repurchase of 2029 convertible senior notes including premium (350,885) 0
Proceeds from exercise of stock options 32,570 4,706
Proceeds from issuances under the employee stock purchase plan 2,356 1,537
Net cash provided by financing activities 191,721 5,193
Effect of exchange rate changes on cash 12 2,497
Net increase in cash and cash equivalents 24,700 16,619
Cash and cash equivalents, beginning of year 93,035 58,535
Cash and cash equivalents, end of period $ 117,735 $ 75,154